Related Experiment Video

Updated: May 5, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

12.5K

Treatment of experimental murine Coxsackie B3 myocarditis

M Herzum1, S A Huber, R Weller

  • 1Philipps University, Department of Internal Medicine-Cardiology, Marburg, Germany.

European Heart Journal
|August 1, 1991
PubMed

Insights

This study investigated immunosuppressive drugs for coxsackievirus B3 myocarditis in mice. Different mouse strains showed varied responses, indicating distinct immune mechanisms in myocarditis.

Area of Science:

  • Immunology
  • Virology
  • Cardiovascular Research

Background:

  • Myocarditis, an inflammation of the heart muscle, can be caused by viral infections like coxsackievirus B3.
  • Understanding the immune response is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the efficacy of immunosuppressive agents in a murine model of coxsackievirus B3-induced myocarditis.
  • To explore the influence of genetic background on disease progression and treatment response.

Main Methods:

  • Utilized a murine model of coxsackievirus B3-induced myocarditis.
  • Administered various immunosuppressive agents to genetically distinct strains of inbred mice.
  • Monitored disease course and outcome.

Main Results:

  • Significant variations in treatment response were observed across different mouse strains.
  • Drug efficacy was strain-dependent, highlighting genetic influences on disease pathogenesis.
  • Immune pathomechanisms mediating myocarditis differ among mouse strains.

Conclusions:

  • Genetic factors play a critical role in the immune response to coxsackievirus B3-induced myocarditis.
  • Immunosuppressive therapy outcomes are influenced by the host's genetic makeup.
  • Further research into strain-specific immune pathways is warranted for targeted myocarditis treatment.

More Related Videos

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

29.5K
Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

30.5K

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
361
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
496
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
344
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
400
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
592